BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15450562)

  • 21. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
    Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
    Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan in aortic valve surgery: cardiac performance and recovery.
    Järvelä K; Maaranen P; Sisto T; Ruokonen E
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):693-8. PubMed ID: 18922425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery bypass surgery in patients with impaired left ventricular function. Predictors of hospital outcome.
    Soliman Hamad MA; Peels K; Van Straten A; Van Zundert A; Schönberger J
    Acta Anaesthesiol Belg; 2007; 58(1):37-44. PubMed ID: 17486923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative treatment with angiotensin-converting enzyme inhibitors in patients with preoperative reduced left ventricular systolic function.
    Villacorta J; Oddoze C; Giorgi R; Kerbaul F; Bonnet M; Collart F; Gouin F; Guidon C
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):187-91. PubMed ID: 18375318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
    Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
    Ulas MM; Hizarci M; Kunt A; Ergun K; Kocabeyoglu SS; Korkmaz K; Lafci G; Gedik S; Cagli K
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):518-23. PubMed ID: 19034033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery.
    Berkan O; Katrancioglu N; Ozker E; Ozerdem G; Bakici Z; Yilmaz MB
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):91-5. PubMed ID: 19241310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protective effects of preconditioning decline in aged patients undergoing coronary artery bypass grafting.
    Wu ZK; Pehkonen E; Laurikka J; Kaukinen L; Honkonen EL; Kaukinen S; Laippala P; Tarkka MR
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):972-8. PubMed ID: 11689803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction.
    Nardi P; Pellegrino A; Scafuri A; Colella D; Bassano C; Polisca P; Chiariello L
    Ann Thorac Surg; 2009 May; 87(5):1401-7. PubMed ID: 19379873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery.
    Choi YS; Kwak YL; Kim JC; Chun DH; Hong SW; Shim JK
    Anaesthesia; 2009 Aug; 64(8):871-7. PubMed ID: 19604191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoflurane produces only minor preconditioning in coronary artery bypass grafting.
    Wang X; Järvinen O; Kuukasjärvi P; Laurikka J; Wei M; Rinne T; Honkonen EL; Tarkka M
    Scand Cardiovasc J; 2004 Oct; 38(5):287-92. PubMed ID: 15513312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in pulmonary microvascular pressure following cardiopulmonary bypass: beneficial effects of dobutamine.
    O-Yurvati AH; Laub GW; Sanders SP; Dullye LJ; Reibman JB; McGrath LB
    Int Surg; 1995; 80(3):231-4. PubMed ID: 8775609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
    Budeus M; Hennersdorf M; Perings S; Röhlen S; Schnitzler S; Felix O; Reimert K; Feindt P; Gams E; Lehmann N; Wieneke H; Sack S; Erbel R; Perings C
    Eur Heart J; 2006 Jul; 27(13):1584-91. PubMed ID: 16760210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-operative effects of olprinone after coronary artery bypass grafting.
    Orime Y; Shiono M; Hata H; Yagi S; Tsukamoto S; Kimura S; Ohmiya S; Sezai A; Yamada H; Obana M; Sezai Y
    Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):340-6. PubMed ID: 9914463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamics in off-pump surgery: normal versus compromised preoperative left ventricular function.
    Fiore G; Latrofa ME; Tunzi P; Traversa M; Fondacone C; Marraudino N; de Luca Tupputi Schinosa L; Fiore T
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):488-93. PubMed ID: 15740961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group.
    Bennett-Guerrero E; Jimenez JL; White WD; D'Amico EB; Baldwin BI; Schwinn DA
    JAMA; 1996 Mar; 275(9):687-92. PubMed ID: 8594265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.